Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe “PREPARE” study
Evangelia Eirini Tsermpini(University of Patras), GP Patrinos(University of Patras), Panagiotis Ferentinos(National and Kapodistrian University of Athens), Eleni Georgila, Μαρία Σκώκου(University of Patras), Konstantinos Assimakopoulos, Philippos Gourzis(University of Patras)
Cited by 9
Related Papers
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
|The Lancet|2023|508
Perfusion abnormalities in mild cognitive impairment and mild dementia in Alzheimer’s disease measured by pulsed arterial spin labeling MRI
|European Archives of Psychiatry and Clinical Neuroscience|2011|124
Complex posttraumatic stress disorder: The need to consolidate a distinct clinical syndrome or to reevaluate features of psychiatric disorders following interpersonal trauma?
|World Journal of Psychiatry|2018|91
Depression in Multiple Sclerosis: A Review of Assessment and Treatment Approaches in Adult and Pediatric Populations
|ISRN Neurology|2012|84
Suicidality in the “prodromal” phase of schizophrenia
|Comprehensive Psychiatry|2010|67